NCT01219582View on ClinicalTrials.gov

GLucobay M OBservation Study for Efficacy and Safety in Treatment of Type-2 Diabetes Patients

CompletedOBSERVATIONAL
Enrollment

9,364

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

January 31, 2012

Study Completion Date

December 31, 2012

Conditions
Type 2 Diabetes
Interventions
DRUG

Glucobay M (Acarbose/Metformin, BAY81-9783)

Oral Glucobay-M 25 every 8 hours (Q8H) titrated to Glucobay-M 50 Q8H or as per investigators discretion.

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT01219582 - GLucobay M OBservation Study for Efficacy and Safety in Treatment of Type-2 Diabetes Patients | Biotech Hunter | Biotech Hunter